High Dose Inhaled Mannitol Study
NCT01076491 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2010-02-26
Summary
This study is to investigate the safety and tolerability of high doses of inhaled mannitol in subjects with bronchiectasis to further direct development of an improved drug delivery system.
Conditions
Interventions
- DRUG
-
mannitol
inhaled mannitol - single doses of either 70 mg or 90 mg
Sponsors & Collaborators
-
Syntara
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2009-03-31
- Completion
- 2009-04-30
Countries
- Australia
Study Locations
More Related Trials
-
Nasal Muco-ciliary Clearance Study With and Without Salt Inhalation
NCT04189016 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701)
NCT01381666 ·Status: TERMINATED ·Phase: PHASE2
-
Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis
NCT02509091 ·Status: UNKNOWN ·Phase: PHASE4
-
Explorative Clinical Investigation to Investigate the Ability of PreciseInhale to Direct Regional Lung Targeting and Reduce the Degree of Throat Deposition and Subsequent Gastrointestinal Absorption in Healthy Volunteers After Inhalation of Test Drug Substances Via the PreciseInhale System
NCT04946630 ·Status: COMPLETED ·Phase: NA
-
Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.
NCT02096315 ·Status: TERMINATED ·Phase: PHASE2
-
Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175
NCT05628740 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis
NCT01677403 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis
NCT03903913 ·Status: UNKNOWN ·Phase: PHASE2
-
Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device
NCT04631354 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler DPI
NCT02018549 ·Status: COMPLETED ·Phase: PHASE2
-
COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2
NCT04858451 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection
NCT04544215 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa)
NCT06663176 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study To Determine Effects Of Fluticasone Propionate On Sputum Neutrophils After Inhaled Lipopolysaccharide Challenge In Volunteers
NCT01364519 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
NCT07201051 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
NCT07284459 ·Status: RECRUITING ·Phase: PHASE2
-
The Leaky Lung Test
NCT02306473 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound
NCT03829618 ·Status: TERMINATED ·Phase: PHASE3
-
Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis
NCT05743946 ·Status: COMPLETED ·Phase: PHASE4
-
Advanced Immunological Approach in COPD Exacerbation
NCT02417649 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
NCT06603246 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
NCT03591926 ·Status: WITHDRAWN ·Phase: PHASE2
-
Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis
NCT02035488 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis
NCT02081963 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety of Tuberculosis Treatments by Oral Inhalation
NCT01785927 ·Status: UNKNOWN ·Phase: PHASE1